Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Depletion of Glucose Activates Catabolite Repression during Pneumonic Plague.

Ritzert JT, Lathem WW.

J Bacteriol. 2018 May 9;200(11). pii: e00737-17. doi: 10.1128/JB.00737-17. Print 2018 Jun 1.

2.

Generation and Validation of the iKp1289 Metabolic Model for Klebsiella pneumoniae KPPR1.

Henry CS, Rotman E, Lathem WW, Tyo KE, Hauser AR, Mandel MJ.

J Infect Dis. 2017 Feb 15;215(suppl_1):S37-S43. doi: 10.1093/infdis/jiw465.

3.

Proteolysis of plasminogen activator inhibitor-1 by Yersinia pestis remodulates the host environment to promote virulence.

Eddy JL, Schroeder JA, Zimbler DL, Caulfield AJ, Lathem WW.

J Thromb Haemost. 2016 Sep;14(9):1833-43. doi: 10.1111/jth.13408. Epub 2016 Aug 19.

4.

Draft Genome Sequence of a Multidrug-Resistant Klebsiella quasipneumoniae subsp. similipneumoniae Isolate from a Clinical Source.

Ozer EA, Morris AR, Krapp F, Henry CS, Tyo KE, Lathem WW, Hauser AR.

Genome Announc. 2016 May 26;4(3). pii: e00422-16. doi: 10.1128/genomeA.00422-16.

5.

Inactivation of Peroxiredoxin 6 by the Pla Protease of Yersinia pestis.

Zimbler DL, Eddy JL, Schroeder JA, Lathem WW.

Infect Immun. 2015 Nov 9;84(1):365-74. doi: 10.1128/IAI.01168-15. Print 2016 Jan.

6.

Impact of the Pla protease substrate α2-antiplasmin on the progression of primary pneumonic plague.

Eddy JL, Schroeder JA, Zimbler DL, Bellows LE, Lathem WW.

Infect Immun. 2015 Dec;83(12):4837-47. doi: 10.1128/IAI.01086-15. Epub 2015 Oct 5.

7.

Early emergence of Yersinia pestis as a severe respiratory pathogen.

Zimbler DL, Schroeder JA, Eddy JL, Lathem WW.

Nat Commun. 2015 Jun 30;6:7487. doi: 10.1038/ncomms8487.

8.

Production of outer membrane vesicles by the plague pathogen Yersinia pestis.

Eddy JL, Gielda LM, Caulfield AJ, Rangel SM, Lathem WW.

PLoS One. 2014 Sep 8;9(9):e107002. doi: 10.1371/journal.pone.0107002. eCollection 2014.

9.

Disruption of fas-fas ligand signaling, apoptosis, and innate immunity by bacterial pathogens.

Caulfield AJ, Lathem WW.

PLoS Pathog. 2014 Aug 7;10(8):e1004252. doi: 10.1371/journal.ppat.1004252. eCollection 2014 Aug. Review. No abstract available.

10.

The Pla protease of Yersinia pestis degrades fas ligand to manipulate host cell death and inflammation.

Caulfield AJ, Walker ME, Gielda LM, Lathem WW.

Cell Host Microbe. 2014 Apr 9;15(4):424-34. doi: 10.1016/j.chom.2014.03.005.

11.

Genome-wide analysis of small RNAs expressed by Yersinia pestis identifies a regulator of the Yop-Ysc type III secretion system.

Schiano CA, Koo JT, Schipma MJ, Caulfield AJ, Jafari N, Lathem WW.

J Bacteriol. 2014 May;196(9):1659-70. doi: 10.1128/JB.01456-13. Epub 2014 Feb 14.

12.

Posttranscriptional regulation of the Yersinia pestis cyclic AMP receptor protein Crp and impact on virulence.

Lathem WW, Schroeder JA, Bellows LE, Ritzert JT, Koo JT, Price PA, Caulfield AJ, Goldman WE.

MBio. 2014 Feb 11;5(1):e01038-13. doi: 10.1128/mBio.01038-13.

13.

RfaL is required for Yersinia pestis type III secretion and virulence.

Houppert AS, Bohman L, Merritt PM, Cole CB, Caulfield AJ, Lathem WW, Marketon MM.

Infect Immun. 2013 Apr;81(4):1186-97. doi: 10.1128/IAI.01417-12. Epub 2013 Jan 28.

14.

Post-transcriptional regulation of gene expression in Yersinia species.

Schiano CA, Lathem WW.

Front Cell Infect Microbiol. 2012 Nov 9;2:129. doi: 10.3389/fcimb.2012.00129. eCollection 2012. Review.

15.

Hfq-dependent, co-ordinate control of cyclic diguanylate synthesis and catabolism in the plague pathogen Yersinia pestis.

Bellows LE, Koestler BJ, Karaba SM, Waters CM, Lathem WW.

Mol Microbiol. 2012 Nov;86(3):661-74. doi: 10.1111/mmi.12011. Epub 2012 Sep 7.

16.

Global discovery of small noncoding RNAs in pathogenic Yersinia species.

Koo JT, Lathem WW.

Adv Exp Med Biol. 2012;954:305-14. doi: 10.1007/978-1-4614-3561-7_38. Review. No abstract available.

17.

Substrates of the plasminogen activator protease of Yersinia pestis.

Caulfield AJ, Lathem WW.

Adv Exp Med Biol. 2012;954:253-60. doi: 10.1007/978-1-4614-3561-7_32. Review. No abstract available.

18.

Identification of small, noncoding RNAs in pathogenic Yersinia species: implications for evolution and virulence.

Lathem WW.

Virulence. 2012 Mar-Apr;3(2):154-6. doi: 10.4161/viru.19155. Epub 2012 Mar 1. No abstract available.

19.

Global discovery of small RNAs in Yersinia pseudotuberculosis identifies Yersinia-specific small, noncoding RNAs required for virulence.

Koo JT, Alleyne TM, Schiano CA, Jafari N, Lathem WW.

Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):E709-17. doi: 10.1073/pnas.1101655108. Epub 2011 Aug 29.

20.

The small RNA chaperone Hfq is required for the virulence of Yersinia pseudotuberculosis.

Schiano CA, Bellows LE, Lathem WW.

Infect Immun. 2010 May;78(5):2034-44. doi: 10.1128/IAI.01046-09. Epub 2010 Mar 15.

21.

A plasminogen-activating protease specifically controls the development of primary pneumonic plague.

Lathem WW, Price PA, Miller VL, Goldman WE.

Science. 2007 Jan 26;315(5811):509-13.

22.

RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague.

Cathelyn JS, Crosby SD, Lathem WW, Goldman WE, Miller VL.

Proc Natl Acad Sci U S A. 2006 Sep 5;103(36):13514-9. Epub 2006 Aug 28.

23.

Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity.

Lathem WW, Crosby SD, Miller VL, Goldman WE.

Proc Natl Acad Sci U S A. 2005 Dec 6;102(49):17786-91. Epub 2005 Nov 23.

24.
25.
26.

Acquisition of stcE, a C1 esterase inhibitor-specific metalloprotease, during the evolution of Escherichia coli O157:H7.

Lathem WW, Bergsbaken T, Witowski SE, Perna NT, Welch RA.

J Infect Dis. 2003 Jun 15;187(12):1907-14. Epub 2003 Jun 4.

PMID:
12792867
27.

StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor.

Lathem WW, Grys TE, Witowski SE, Torres AG, Kaper JB, Tarr PI, Welch RA.

Mol Microbiol. 2002 Jul;45(2):277-88.

28.

Ser727-dependent recruitment of MCM5 by Stat1alpha in IFN-gamma-induced transcriptional activation.

Zhang JJ, Zhao Y, Chait BT, Lathem WW, Ritzi M, Knippers R, Darnell JE Jr.

EMBO J. 1998 Dec 1;17(23):6963-71.

29.

Stat3 activation is required for cellular transformation by v-src.

Bromberg JF, Horvath CM, Besser D, Lathem WW, Darnell JE Jr.

Mol Cell Biol. 1998 May;18(5):2553-8.

Supplemental Content

Loading ...
Support Center